000 01467 a2200385 4500
005 20250514224851.0
264 0 _c20051230
008 200512s 0 0 eng d
022 _a1744-6872
024 7 _a10.1097/01213011-200505000-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMaitland-van der Zee, Anke-Hilse
245 0 0 _aA multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide.
_h[electronic resource]
260 _bPharmacogenetics and genomics
_cMay 2005
300 _a287-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntihypertensive Agents
_xpharmacology
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCytochrome P-450 CYP11B2
_xgenetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydrochlorothiazide
_xpharmacology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNitric Oxide Synthase
_xgenetics
650 0 4 _aPolymorphism, Genetic
650 0 4 _aSodium Channels
_xgenetics
700 1 _aTurner, Stephen T
700 1 _aSchwartz, Gary L
700 1 _aChapman, Arlene B
700 1 _aKlungel, Olaf H
700 1 _aBoerwinkle, Eric
773 0 _tPharmacogenetics and genomics
_gvol. 15
_gno. 5
_gp. 287-93
856 4 0 _uhttps://doi.org/10.1097/01213011-200505000-00003
_zAvailable from publisher's website
999 _c15530674
_d15530674